Skip to main content
. 2014 Jan;12(1):40–49. doi: 10.2450/2013.0088-13

Table I.

Direct supply, operating and hospitalisation costs associated with leucodepleted allogeneic red cell concentrate (ARC) and post-operative intravenous (IV) iron therapy.

Supply costs
ARC acquisition cost (per unit) 155
Iron sucrose (per 100 mg)* 8.5
Ferric carboxymaltose (per 100 mg) 20
Iron isomaltoside 1,000 (per 100 mg) 20
Low molecular weight iron dextran (per 100 mg) 10.3
Saline and giving set (per infusion) 2

Operating costs

ARC transfusion cost (per unit) 52
IV iron infusion (per infusion)** 16
Haemoglobin assessment (per measurement) 36

Hospitalisation cost

Hospitalisation in the orthopaedic ward (per day) 320
*

Mean cost of three available products;

**

Except for low molecular weight iron dextran which is estimated at €48.